Form 4 for DGX Quest Diagnostics
Accepted 2025-01-31 00:00:00 ET · period of report 2025-01-29 · accession 0001022079-25-000018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-31 | 2025-01-29 | DGX | Gregg Vicky B | Dir | L - Small Acq | $158.04 | +72 | 18.1K | +0.4% | +$11.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-29 | L | A | 72 | $158.04 | 18,117 | D | — | — | (F1) The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. |